LogiPharma Asia 2024 Blog

In the past, the commercial and supply chain functions have operated in silos, hindering their ability to work towards a common and unified goal. This thought leadership article explores the power of breaking down these siloes, bridging the gap and fostering collaboration between these teams.

Chee Yong Ng shares his insights on the sales funnel strategy, whereby emerging prospects are dependent on customers’ confidence level and their behaviour that guide every decision they make. It will help them to strike a balance when resolving supply and demand issues alongside aligning those numbers with internal growth targets, avoiding risks tied to compromised run rates.

“Health is wealth” was the key global takeaway from the pandemic. It highlighted how critical the pharmaceutical supply chain was and still is - to ensure the prompt and proper delivery of medical products. However, it also exposed gaps made more prominent over the pre-pandemic years.

This article entails some of the critical challenges faced by pharmaceutical supply chains involved in Asia and strategic insights on how to tackle these challenges. Let’s get unpacking!

As pharma leaders, transitioning to proactive, resilient strategies is no longer an option but a necessity. What happens when the next world crisis hits? What happens if we have a COVID 2.0, war breaks out, or an economy upends without warning?

Modern businesses must move beyond crisis-driven responses to establish supply chains designed not just to cope with sudden disruptions that may surface but thrive within an ever-changing and uncertain terrain.

This guide will explore actionable and future-proof strategies to execute pharma supply chain management and ensure preparedness in the event of another global challenge.

You are no stronger than your weakest link. We invited Robert Paterson, Regional Commercial Manager - APAC - Tower Cold Chain, Mitchell Coats, General Manager Pharma Vertical, EFL Global - India, Tsu Rasolonjatovo, Global Logistics Transformation Leader & Global Process Owner, Elanco, and Dr Arani Chatterjee to give us their thoughts of what constitutes a successful partnership: the importance they have to the business, what makes each partnership exceptional and what criteria you must use to access their value.

We hear how “pharma companies are always seeking a single version of truth” - and their perspectives on the benefits real-time visibility brings - whether that’s allowing you to consolidate information from various supplier sources to know exactly what is happening and when or improving partner relationships. Listen as our speakers describe why a lot of scenario planning must be incorporated into the supply chain if you’re looking to improve resilience and risk mitigation strategies.

When we talk about digital transformation - what do we mean? Digital transformation means something to everyone, it’s subjective and specific to the needs of your business. We invited Derek Less, VP Pharma & Healthcare, APAC JAS Worldwide, Christoph Bamert, Global Head of Sales & marketing, MD APAC ELPRO, Chris Edwards, Senior Vice President - Asia Pacific One Network Enterprises and Gaurav Bhatia, General Manager Reliance Retail, to talk to us about what digital transformation means to them - what drives the decisions, the partnerships, the investment decisions and ultimately delights the customer.

In this exclusive interview, we invited Ana Martinez Lozano, Assistant Director Distribution & Logistics Quality EMEA Lead at MSD, Marco Gaudesi, Head of GSDP & Cold Chain at MSF (Doctors without Borders), and Henri Lee, Group Managing Director at Aeris Dynamics to give us insights on the latest technology to better improve a temperature sensitive and controlled shipment, tips on how common challenges in this area can be mitigated, and other precautions that needs to be considered when transporting medicine such as counterfeit goods and security.

In this exclusive interview, we brought Yang Yan, Sales Manager at Beijing CIMC Lengyun Technology Co., Ltd, Wallace Tay, Managing Director at va-Q-tec Singapore, Patrick Blain, Global Sales Director at Emball’iso, Prathyusha Parakala, Program Manager for Sustainability at Dr Reddy’s Laboratories, and Remi Cesaro, Founder & Executive Director at Zero Waste City together to share about their thoughts on this topic, including how much attention should be paid in creating sustainable supply chains in your company (and how important it is for leadership to have the vision for the long-term thinking of how sustainability matters), and the challenges faced.

For this exclusive interview, we spoke to Nikkita Johal, Assistant Director - Global Compliance Monitoring at Gilead Sciences, Shawn Lim, Senior Supply Chain Manager at Santen Asia, Mohit Agarwal, Head of Emerging Markets - SFE at Sun Pharma, and Shirish Ambulgekar, Vice President - Corporate Quality at Sun Pharma about the struggles they’ve experienced in recruiting and retaining young and qualified talent. They also share about what the company has done to overcome the issue, such as using data-driven approaches when developing talent in the supply chain industry.

Ravinder Dhar, Director of Supply Chain - APAC Markets at Teva Pharma Australia shares with us the tips he has for large companies looking to drive transformation in their end-to-end supply chain. The supply chain process in pharma is extremely complicated as it’s highly regulated, and starting with a clear strategy is important to the transformation, knowing whether you’d like to build a supply chain that is customer-centric or cost-effective.

Join Fais Adha, Head of Supply Chain for Malaysian Healthcare provider - IE Direct as he talks to us about the unique challenges in Regulatory Compliance, Intellectual Property Protection and Collaboration & Trust in Pharma. Fais dives into supply chain bridging - what’s changed and why, why blockchain’s immutable record feature is beneficial in Pharma and how tech trends meet market needs.

In this quick-fire Q&A - Ana Martinez Lozano, Associate Director Distribution & Logistics Quality EMEA Lead, MSD, give us a window into the pharma giant MSD’s perspective on key concerns facing our industry today. We discuss the changes brought on by Ai & ML and how MSD has adapted their processes and tech to keep up. We talk Blockchain, obstacles as a big pharma player and obstacles when embedding new systems.

In this exclusive interview, Pratyusha Parakala, Program Manager, Sustainability at Dr Reddy's takes us through her journey to Antarctica and the reason she felt compelled to get closer to the planet to drive sustainability and raise awareness for the causes she supports. She highlights the importance of each person taking the extra step to practice sustainability and the various campaigns she has focused around.

Watch the interview now

Tam Nguyen is a respected voice in the Medtech and Health Tech start-ups community. With over 20 years of experience in clinical trials, health and medical research and having pioneered innovation and advancement in the healthcare sector for many years, Tam joined us for an exclusive interview ahead of LogiPharma Asia.

Successful collaborations can speed up market access and fast-track authorisation to access local markets in different countries. In this article, we explore key strategies and pitfalls to avoid when building a successful pharmaceutical partnership.

Diversification and inclusion are no strangers in pharma. Life science companies today continue to strive to change the narrative of the lack of women taking on leadership roles that would expand their scope of capabilities, directing the new wave of millennial talent in the workforce toward sustainable change in both the public and private sectors. In this blog, we tackle challenges facing pharma companies to find out how to bridge gender & cultural gaps.

Indeed, there is much to be gained through sharing knowledge and experience. In this article, we discuss how pharma can look to innovative solutions being adopted in other industries to discover where technologies and strategies can help industry progression, bringing pharma up to speed in dealing with the demands of today.